Vaccinex annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
Vaccinex Revenue Growth & History (VCNX)
Vaccinex reported $601,000 in revenue for fiscal 2024, an increase of 5.44% from the previous fiscal year.
View full Vaccinex company overviewVaccinex annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $601,000 | $31,000 | +5.44% |
| 2023 | 2023-12-31 | $570,000 | $295,000 | +107.27% |
| 2022 | 2022-12-31 | $275,000 | −$625,000 | −69.44% |
| 2021 | 2021-12-31 | $900,000 | $275,000 | +44.00% |
| 2020 | 2020-12-31 | $625,000 | $102,000 | +19.50% |
| 2019 | 2019-12-31 | $523,000 | −$201,000 | −27.76% |
| 2018 | 2018-12-31 | $724,000 | $634,000 | +704.44% |
| 2017 | 2017-12-31 | $90,000 | — | — |
Vaccinex quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $213,000 | $213,000 | — |
| Q3 2024 | 2024-09-30 | $52,000 | $32,000 | +160.00% |
| Q2 2024 | 2024-06-30 | $232,000 | $232,000 | — |
| Q1 2024 | 2024-03-31 | $104,000 | −$446,000 | −81.09% |
| Q4 2023 | 2023-12-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $20,000 | −$30,000 | −60.00% |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $550,000 | — | — |
| Q3 2022 | 2022-09-30 | $50,000 | $0 | 0.00% |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $50,000 | −$575,000 | −92.00% |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $850,000 | — | — |
| Q3 2020 | 2020-09-30 | $625,000 | $221,000 | +54.70% |
| Q4 2019 | 2019-12-31 | $0 | −$194,000 | −100.00% |
| Q3 2019 | 2019-09-30 | $404,000 | $206,000 | +104.04% |
| Q2 2019 | 2019-06-30 | $25,000 | −$101,000 | −80.16% |
| Q1 2019 | 2019-03-31 | $94,000 | −$112,000 | −54.37% |
| Q4 2018 | 2018-12-31 | $194,000 | — | — |
| Q3 2018 | 2018-09-30 | $198,000 | — | — |
| Q2 2018 | 2018-06-30 | $126,000 | — | — |
| Q1 2018 | 2018-03-31 | $206,000 | — | — |
Vaccinex revenue growth trends
Over the last five reported fiscal years, revenue grew from $523,000 to $601,000, a compound annual growth rate of 2.82%. Vaccinex's latest reported quarter, Q4 2024, generated $213,000 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Vaccinex source filings ↗